THE FOREIGN SERVICE JOURNAL
ANSWERS TO CURRENCY QUIZ
12. The Gambia
National Institutes of Health is having
difficulty conducting a clinical trial of an
experimental Ebola vaccine in Liberia.Reuters reports that NIH may move some
testing to Sierra Leone.The Washington Post paints a picture
of “near-empty” treatment centers, built
by what the
called an “aggressive
American military and civilian response”
that occurred “too late” to help the bulk of
Liberians who were infected.
Major General Gary Volesky, the top
U.S. military officer in Liberia, told the
that no one was “declaring victory” in
light of the dropping infection rate, how-
ever. And the treatment centers are now in
place to be used if the virus resurges.
In fact, the Ebloa epidemic is now in acritical and difficult new phase that global health officials call “getting to zero.”This
involves tracking the thousands of virus
transmission chains, tracing all those who
might have been exposed and monitoring
them for several weeks to make sure they
don’t get sick.
To do that, the U.S. Centers for Disease
Control is increasing its involvement
in the region. It now has 214 staffers in
West Africa—more than at any other time
during the outbreak. The agency plans to
open new offices in Guinea, Liberia and
Sierra Leone in the spring.
As Dr. Margaret Chan, director general
of the World Health Organization, said ina speech to the Executive Board on Ebola at WHO, “The volatile microbial world
will always deliver surprises. Never again
should the world be caught by surprise,
—Debra Blome, Associate EditorTake AFSA With You! Change your address online, visit us at www.afsa.org/address Or Send changes to: AFSAMembership Department 2101 E Street NW Washington, DC 20037 Moving?